Evidence map›Paper›PMID 35770256›Full record

ArticleEClinicalMedicine2022

COVID-19 vaccine hesitancy amongst healthcare workers: An assessment of its magnitude and determinants during the initial phase of national vaccine deployment in Nigeria.

Terna Nomhwange, Oghenebrume Wariri, Esin Nkereuwem, Scholastica Olanrewaju, Ngozi Nwosu, Usman Adamu, Ezekiel Danjuma, Nneka Onuaguluchi, Joseph Enegela, Erdoo Nomhwange and 2 more

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Terna NomhwangeWorld Health Organization Country office, Abuja, Nigeria.
Oghenebrume WaririMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Esin NkereuwemMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Scholastica OlanrewajuDepartment of Strategic Information, Institute of Human Virology, Abuja, Nigeria.
Ngozi NwosuNational Primary Health Care Development Agency (NPHCDA) Abuja, Nigeria.
Usman AdamuNational Primary Health Care Development Agency (NPHCDA) Abuja, Nigeria.
Ezekiel DanjumaWorld Health Organization East and Southern Africa Inter country support team (IST), Harare, Zimbabwe.
Nneka OnuaguluchiAfrica Disease prevention and research development Initiative (ADRAP), Abuja, Nigeria.
Joseph EnegelaAfrica Disease prevention and research development Initiative (ADRAP), Abuja, Nigeria.
Erdoo NomhwangeUniversity of Abuja Teaching Hospital, Abuja, Nigeria.
Anne Eudes Jean BaptisteWorld Health Organization Country office, Abuja, Nigeria.
Walter Kazadi MulomboWorld Health Organization Country office, Abuja, Nigeria.
World Health Organization - Nigeria · NGMRC Unit the Gambia · GMNational Primary Health Care Development Agency · NGInstitute of Human Virology · NGUniversity of Abuja Teaching Hospital · NGWorld Health Organization - Zimbabwe · ZW

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: While vaccination plays a critical role in the global response to the COVID-19 pandemic, vaccine rollout remains suboptimal in Nigeria and other Low- and Middle-income countries (LMICs). This study documents the level of hesitancy among health workers (HWs) during the initial COVID-19 vaccine deployment phase in Nigeria and assesses the magnitude and determinants of hesitancy across Nigeria. Methods: A cross sectional study across all States in Nigeria was conducted with over 10,000 HWs interviewed between March and April 2021. Data were cleaned and analyzed with proportions and confidence intervals of hesitancy documented and stratification by HW category. We compared the level of confidence/acceptance to be vaccinated across Nigeria and documented the sources of negative information amongst HWs who refused the vaccine. Findings: Among the 10 184 HWs interviewed, 9 369 [92% (95% CI= 91, 92)] were confident of the COVID-19 vaccines and were already vaccinated at the time of this survey. Compared to HWs who were less than 20 years old, those aged 50 - 59 years were significantly more confident of the COVID-19 vaccines and had been vaccinated (OR=3.8, 95% CI=2.3 - 6.4, p<0.001). Only 858 (8%) of the HWs interviewed reported being hesitant with 57% (479/858) having received negative information, with the commonest source of information from social media (43.4%.). Interpretation: A vast majority of HWs who were offered COVID-19 vaccines as part of the first phase of national vaccine roll out were vaccinated and reported being confident of the COVID-19 vaccines. The reported hesitancy was due mainly to safety issues, and negative information about vaccines from social media. The issues identified remain a significant risk to the success of subsequent phases of the vaccine rollout in Nigeria. Funding: None.

Indexed as

COVID-19 vaccineHealth workersNigeriaVaccine hesitancy

Identifiers

PMID35770256
PMCPMC9233171
OpenAlexW4283526701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.